Lean and Obese: Dietary Inflammation
LODI
Dietary Inflammation in Older Adults: the Role of Obesity
1 other identifier
interventional
32
1 country
1
Brief Summary
In the Lean and Obese Dietary Inflammation (LODI) study, the primary goal is to determine the effect of short-term intake of high dietary fat (5 days) compared to low fat intake (5 days) in a cross-over design in older adults (men and women) with normal body weight or obesity. Inflammation will be examined by measuring serum endotoxin and other markers, as well as the fecal microbiota.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Mar 2022
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2022
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedFirst Posted
Study publicly available on registry
April 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 11, 2023
CompletedMarch 25, 2024
March 1, 2024
10 months
February 28, 2022
March 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Endotoxin from Low to High fat diet
serum and stool
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Change in Microbiome composition
stool
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Secondary Outcomes (5)
Inflammatory markers
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Zonulin
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Lipopolysaccharide binding protein (LBP)
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Toll like receptor-4 and Null 2 stimulation
Change from LFD (5 days) to HFD (5 days) over an average of 6 weeks
Endotoxin in response to a meal
Change over 5 hour MMT
Other Outcomes (10)
Change in Glucose in response to a meal
Change over 5 hour MMT
Change in insulin in response to a meal
Change over 5 hour MMT
Inflammatory markers in response to a meal
Change over 5 hour MMT
- +7 more other outcomes
Study Arms (2)
Obese
EXPERIMENTALBMI in Obesity range
Normal weight (lean)
EXPERIMENTALNormal body weight
Interventions
Subjects will be asked to adhere to a low fat diet (assigned in random order) and be counseled by a dietitian using 5 days of sample menus, monitored online using a shared nutrient analysis program, and supplied with low fat foods to increase compliance
Subjects will be asked to adhere to a high fat diet that is rich in SFAs (assigned in random order) and be counseled by a dietitian using sample 5 days of menus, monitored online using a shared nutrient analysis program, and supplied with high fat foods to increase compliance
Eligibility Criteria
You may qualify if:
- Men or Women
- Age 50-79 years (only postmenopausal women \> 2 years)
- Body mass index (20-25 kg/m2; and 30-40 kg/m2)\*
You may not qualify if:
- Diagnosed with, active, or history of liver cirrhosis, chronic or persisting hepatitis
- Diagnosed with, active, or history of cancer
- History of gastrointestinal disease or surgical procedure for weight loss.
- Diagnosed with immune diseases, type 2 diabetes, pancreatitis, or infectious diseases
- Any surgery in the past 6 months
- Currently using or have used antibiotics continuously \> 3 days in the past 3 months
- Regular use of medications for that affect the gastrointestinal tract, cholecystitis, urinary tract infection, severe organic diseases including coronary heart disease, myocardial infarction, infectious diseases including pulmonary tuberculosis and AIDS
- Known allergy or intolerance to any ingredients in the dietary intervention program
- Alcohol or illicit drug abuse
- Current Smoker or have quit smoking in the past 3 months
- Recent colonoscopy (within the previous two months)
- Inability to follow any of the experimental diets (including low or high fat diet) or to perform the collections required for this study
- Participants will also be excluded if they have extreme dietary habits, extreme levels of physical or athletic activity, or by changes in body weight \>5 lbs. during the last 6 months
- Uncontrolled hypertension or uncontrolled hyperlipidemia in abnormal ranges.
- Participation in another clinical research trial that may interfere with the results of this study.
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers University
New Brunswick, New Jersey, 08901, United States
Related Publications (1)
Ogilvie AR, Onishi JC, Schlussel Y, Kumar A, Haggblom MM, Kerkhof LJ, Shapses SA. Short-term high fat diet-induced metabolic endotoxemia in older individuals with obesity: a randomized crossover study. Am J Clin Nutr. 2025 Aug;122(2):601-611. doi: 10.1016/j.ajcnut.2025.06.001. Epub 2025 Jun 4.
PMID: 40480607DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sue Shapses, PhD
Rutgers, the State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 28, 2022
First Posted
April 14, 2022
Study Start
March 1, 2022
Primary Completion
January 1, 2023
Study Completion
February 11, 2023
Last Updated
March 25, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data that underlie the results and after deidentification will be shared upon request for researchers who provide a methodologically sound proposal (and IRB approved).